Boris Striepen

21PUBLICATIONS
71CO-AUTHORS
Major global burdens of diseaseCancer geneticsPublic health nutritionCancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 13, 2026
Genomic heterogeneity of NAD(P)H dehydrogenase predisposes Cryptosporidium to clofazimine resistance.

|Nov 24, 2025
Widespread genomic heterogeneity at the type II NAD(P)H dehydrogenase locus predisposes <i>Cryptosporidium</i> to clofazimine resistance.

Gracyn Y Buenconsejo, Sebastian Shaw, Rui Xiao

|Jun 06, 2025
Genetic crosses reveal genomic loci responsible for virulence in <i>Cryptosporidium parvum</i> infection.

Sebastian Shaw, Xue Li, Gracyn Buenconsejo

|Jul 12, 2024
<i>Cryptosporidium</i> impacts epithelial turnover and is resistant to induced death of the host cell.

Bethan A Wallbank, Ryan D Pardy, Igor E Brodsky

|Jun 03, 2024
Intestinal cDC1s provide cues required for CD4+ T cell-mediated resistance to Cryptosporidium.

Ian S Cohn, Bethan A Wallbank, Breanne E Haskins

|May 29, 2024
Transcriptional control of the Cryptosporidium life cycle.

Katelyn A Walzer, Jayesh Tandel, Jessica H Byerly

Pageof 4

Frequent Collaborators

5 joint publications

Sebastian Shaw

4 joint publications

Keenan M O'Dea

3 joint publications

Rui Xiao

3 joint publications

Yi-Wei Chang